Andon Health Co Ltd
Andon Health Co., Ltd. research, develops, produces, and sells health electronics and smart hardware products. It offers D-Itch stick insect bite healer, pulse oximeter, TENS, massager, bodyfat scale, pregnancy rapid test, blood pressure monitor, thermometer, red light allergy reliever, nasal irrigator, nebulizer, and blood glucose meter. Andon Health Co., Ltd. was founded in 1995 and is based in… Read more
Andon Health Co Ltd (002432) - Net Assets
Latest net assets as of September 2025: CN¥22.42 Billion CNY
Based on the latest financial reports, Andon Health Co Ltd (002432) has net assets worth CN¥22.42 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥28.98 Billion) and total liabilities (CN¥6.56 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥22.42 Billion |
| % of Total Assets | 77.36% |
| Annual Growth Rate | 35.73% |
| 5-Year Change | 1079.2% |
| 10-Year Change | 3429.15% |
| Growth Volatility | 158.07 |
Andon Health Co Ltd - Net Assets Trend (2007–2024)
This chart illustrates how Andon Health Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Andon Health Co Ltd (2007–2024)
The table below shows the annual net assets of Andon Health Co Ltd from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥21.49 Billion | +8.40% |
| 2023-12-31 | CN¥19.82 Billion | -1.00% |
| 2022-12-31 | CN¥20.02 Billion | +606.04% |
| 2021-12-31 | CN¥2.84 Billion | +55.62% |
| 2020-12-31 | CN¥1.82 Billion | +14.01% |
| 2019-12-31 | CN¥1.60 Billion | +4.73% |
| 2018-12-31 | CN¥1.53 Billion | +11.49% |
| 2017-12-31 | CN¥1.37 Billion | -11.19% |
| 2016-12-31 | CN¥1.54 Billion | +153.16% |
| 2015-12-31 | CN¥608.95 Million | -19.74% |
| 2014-12-31 | CN¥758.75 Million | +1.47% |
| 2013-12-31 | CN¥747.77 Million | -1.32% |
| 2012-12-31 | CN¥757.75 Million | -2.29% |
| 2011-12-31 | CN¥775.55 Million | -0.57% |
| 2010-12-31 | CN¥779.96 Million | +337.23% |
| 2009-12-31 | CN¥178.39 Million | +28.02% |
| 2008-12-31 | CN¥139.34 Million | +16.82% |
| 2007-12-31 | CN¥119.28 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Andon Health Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 79190.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥18.15 Billion | 87.54% |
| Common Stock | CN¥492.80 Million | 2.38% |
| Other Comprehensive Income | CN¥2.02 Billion | 9.72% |
| Other Components | CN¥76.66 Million | 0.37% |
| Total Equity | CN¥20.74 Billion | 100.00% |
Andon Health Co Ltd Competitors by Market Cap
The table below lists competitors of Andon Health Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Warby Parker Inc
NYSE:WRBY
|
$2.12 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
$2.12 Billion |
|
Ninestar Corp
SHE:002180
|
$2.12 Billion |
|
Kinetik Holdings Inc
NYSE:KNTK
|
$2.12 Billion |
|
Hoshine Silicon Ind Co Ltd
SHG:603260
|
$2.11 Billion |
|
Adata Technology Co Ltd
TWO:3260
|
$2.11 Billion |
|
Acter Co Ltd
TWO:5536
|
$2.11 Billion |
|
Keda Clean Energy Co Ltd
SHG:600499
|
$2.11 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Andon Health Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 19,229,372,817 to 20,736,503,543, a change of 1,507,130,726 (7.8%).
- Net income of 1,668,727,343 contributed positively to equity growth.
- Dividend payments of 190,655,711 reduced retained earnings.
- Other comprehensive income increased equity by 2,015,294,465.
- Other factors decreased equity by 1,986,235,371.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.67 Billion | +8.05% |
| Dividends Paid | CN¥190.66 Million | -0.92% |
| Other Comprehensive Income | CN¥2.02 Billion | +9.72% |
| Other Changes | CN¥-1.99 Billion | -9.58% |
| Total Change | CN¥- | 7.84% |
Book Value vs Market Value Analysis
This analysis compares Andon Health Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.16x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 136.78x to 1.16x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.40 | CN¥54.50 | x |
| 2008-12-31 | CN¥0.50 | CN¥54.50 | x |
| 2009-12-31 | CN¥0.64 | CN¥54.50 | x |
| 2010-12-31 | CN¥2.41 | CN¥54.50 | x |
| 2011-12-31 | CN¥1.99 | CN¥54.50 | x |
| 2012-12-31 | CN¥2.17 | CN¥54.50 | x |
| 2013-12-31 | CN¥1.63 | CN¥54.50 | x |
| 2014-12-31 | CN¥2.23 | CN¥54.50 | x |
| 2015-12-31 | CN¥1.66 | CN¥54.50 | x |
| 2016-12-31 | CN¥4.25 | CN¥54.50 | x |
| 2017-12-31 | CN¥3.14 | CN¥54.50 | x |
| 2018-12-31 | CN¥3.65 | CN¥54.50 | x |
| 2019-12-31 | CN¥3.84 | CN¥54.50 | x |
| 2020-12-31 | CN¥4.35 | CN¥54.50 | x |
| 2021-12-31 | CN¥6.32 | CN¥54.50 | x |
| 2022-12-31 | CN¥41.84 | CN¥54.50 | x |
| 2023-12-31 | CN¥42.52 | CN¥54.50 | x |
| 2024-12-31 | CN¥47.02 | CN¥54.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Andon Health Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.05%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 64.38%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.27x
- Recent ROE (8.05%) is below the historical average (10.99%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 36.81% | 20.24% | 1.43x | 1.27x | CN¥31.98 Million |
| 2008 | 22.47% | 11.20% | 1.36x | 1.47x | CN¥17.37 Million |
| 2009 | 21.89% | 12.47% | 1.32x | 1.33x | CN¥21.20 Million |
| 2010 | 3.04% | 7.94% | 0.36x | 1.05x | CN¥-54.28 Million |
| 2011 | 2.68% | 5.91% | 0.42x | 1.08x | CN¥-56.75 Million |
| 2012 | 0.92% | 1.96% | 0.44x | 1.08x | CN¥-68.79 Million |
| 2013 | -1.23% | -2.25% | 0.44x | 1.25x | CN¥-83.94 Million |
| 2014 | 1.34% | 2.40% | 0.42x | 1.32x | CN¥-65.68 Million |
| 2015 | -24.76% | -37.89% | 0.49x | 1.35x | CN¥-211.66 Million |
| 2016 | 0.94% | 3.45% | 0.18x | 1.53x | CN¥-139.66 Million |
| 2017 | -12.11% | -27.74% | 0.28x | 1.53x | CN¥-302.77 Million |
| 2018 | 0.82% | 2.25% | 0.30x | 1.24x | CN¥-141.58 Million |
| 2019 | 4.00% | 9.41% | 0.36x | 1.17x | CN¥-99.80 Million |
| 2020 | 12.86% | 12.07% | 0.82x | 1.30x | CN¥53.85 Million |
| 2021 | 31.63% | 37.91% | 0.61x | 1.37x | CN¥621.38 Million |
| 2022 | 81.98% | 60.92% | 1.21x | 1.11x | CN¥14.07 Billion |
| 2023 | 6.51% | 38.74% | 0.14x | 1.18x | CN¥-671.33 Million |
| 2024 | 8.05% | 64.38% | 0.10x | 1.27x | CN¥-404.92 Million |
Industry Comparison
This section compares Andon Health Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,411,839,422
- Average return on equity (ROE) among peers: 13.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Andon Health Co Ltd (002432) | CN¥22.42 Billion | 36.81% | 0.29x | $2.12 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |